The U.S. Court of Appeals for the Federal Circuit in Washington, D.C., has sided with EOFlow in its patent spat with Insulet (Nasdaq:PODD). In its decision, the court overturned a verdict from 2024 that ordered EOFlow to pay nearly $60 million to Insulet. A jury found that EOFlow and several other defendants misappropriated Insulet’s trade secrets […]
Legal News
Abbott wins appeal for preliminary injunction against Sinocare in CGM patent spat
The Unified Patent Court (UPC) Court of Appeal granted Abbott (NYSE:ABT) a preliminary injunction in its patent battle against Sinocare. Abbott’s preliminary injunction victory means Sinocare is banned from selling its iCan i3 continuous glucose monitor (CGM) offering in UPC territory. The UPC decision overturned a prior ruling from a local division (LD) of The […]
Judge tosses class action suit accusing Abbott of sharing CGM data with Meta, Google
An Illinois judge sided with Abbott (NYSE:ABT) in a lawsuit related to alleged data sharing with its continuous glucose monitors (CGMs). In September 2024, a lawsuit filed in the Northern District of Illinois alleged that tracking tools on Abbott’s FreeStyle Libre website expose private consumer information without their knowledge or consent. The company’s FreeStyle.Abbott website […]
Glucose monitor maker LifeScan is set to emerge from Ch. 11 bankruptcy
LifeScan announced that its Chapter 11 bankruptcy reorganization plan received U.S. Bankruptcy Court approval. The U.S. Bankruptcy Court for the Southern District of Texas approved the company’s Chapter 11 plan. With the approval, LifeScan said it’s positioned to emerge from its financial restructuring process by the end of the year. Malvern, Pennsylvania-based LifeScan said in […]
Dexcom is facing a class action suit related to G7 CGM
A class action lawsuit has been filed against Dexcom (Nasdaq:DXCM) in the U.S. District Court for the Central District of California. The lawsuit, led by plaintiff Kelly Grisoli on behalf of all others similarly situated, demands a jury trial for claims that Dexcom’s representations for its latest-generation G7 continuous glucose monitor (CGM) were false, misleading, […]
Baxter faces investor lawsuit over infusion pumps
Investors have filed a lawsuit claiming Baxter (NYSE:BAX) violated federal securities laws as a result of issues with certain infusion pumps. Bloomberg Law first reported the filing of the lawsuit in Illinois. The class action suit seeks a trial by jury as investors hope to recover damages related to the rollout of its Novum IQ […]
Court sides with Medtronic in insulin pump class action suit
A Minnesota judge has dismissed a class action lawsuit alleging securities fraud related to insulin pumps made by Medtronic (NYSE:MDT). Laura M. Provinzino, U.S. District Judge for the District of Minnesota, granted Medtronic’s motion to dismiss the suit initially brought forward by investors in 2022. Provinzino’s dismissal comes about a year-and-a-half after Katherine M. Menendez, […]
Court dismisses several claims against Dexcom in securities lawsuit
A California judge has dismissed several claims against Dexcom (Nasdaq:DXCM) officials related to alleged misrepresentation of sales efforts. Judge Robert S. Huie of the Southern District of California ruled in the consolidated action, which combines three securities class actions against the San Diego-based continuous glucose monitor (CGM) maker. Huie’s judgment denied Dexcom’s motion to dismiss […]
Tandem agrees to pay $36M to settle Roche patent litigation
Tandem Diabetes Care (Nasdaq:TNDM) recently filed an SEC Form 8-K announcing its entry into a patent litigation settlement with Roche. The two companies entered into a settlement, mutual release and cross-license agreement. It resolves all actual or potential patent disputes as of May 21. According to the SEC filing, the settlement relates to Tandem’s t:slim […]
BD files patent infringement lawsuit against Baxter over infusion pump tech
BD (NYSE:BDX) filed a lawsuit in a U.S. District Court alleging patent infringement by Baxter (NYSE:BAX) related to infusion pump technology. The company filed its complaint in the U.S. District Court for the District of Delaware on May 12, 2025. BD’s complaint singles out six specific patents: the “180,” “058,” “880,” “868,” “414,” and “703” […]
